Ore Holdings Inc. (ORXE)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
610 PROFESSIONAL DRIVE GAITHERSBURG, MD 20879

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

Ore Holdings Inc provides innovative drug discovery and development solutions to the pharmaceutical industry. The company's solutions consist of: Genomics and Toxicogenomics Services, Preclinical Contract Research Services and Drug Repositioning and Selection Services.

Data derived from most recent annual or quarterly report
Market Cap 2.188 Million Shares Outstanding5.47 Million Avg 30-day Volume 63.524 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-2.15
Price to Revenue31.4986 Debt to Equity0.0 EBITDA-33.382 Million
Price to Book Value2.6665 Operating Margin-358.9646 Enterprise Value217.946 Million
Current Ratio7.516 EPS Growth0.721 Quick Ratio6.953
1 Yr BETA 52-week High/Low 0.0 / Profit Margin-363.205
Operating Cash Flow Growth-45.7097 Altman Z-Score13.1882 Free Cash Flow to Firm -55.319 Million
View SEC Filings from ORXE instead.

View recent insider trading info

Funds Holding ORXE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ORXE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GIBSON TERRY CEO AND CFO

  • Officer
  • SEE EXPLANATION OF RESPONSES
0 2010-10-29 0

STEEL PARTNERS, LTD.

LICHTENSTEIN WARREN G

  • 10% Owner
3,568,000 2010-10-27 0

HOWARD JACK L

EMH HOWARD LLC

  • Director
  • SEE EXPLANATION OF RESPONSESSEE EXPLANATION OF RESPONSES
200,000 2010-10-22 0

KONG KENNETH

  • Director
  • SEE EXPLANATION OF RESPONSES
0 2010-10-22 0

PALLEIKO BENJAMIN L SVP & CHIEF FINANCIAL OFFICER

  • Officer
0 2010-01-18 0

DONAHUE STEPHEN R SENIOR VICE PRESIDENT

  • Officer
0 2010-01-18 0

GABRIELSON MARK J CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
14,000 2009-11-30 0

FORDYCE JAMES W

  • Director
10,000 2009-11-27 0

GORRY G ANTHONY PHD

  • Director
0 2009-10-20 0

THOMPSON J STARK PHD

  • Director
0 2009-10-20 0

URDAL DAVID

  • Director
0 2009-10-20 0

DUNNE CHRIS T PRINCIPAL ACCOUNTING OFFICER

  • Officer
7,514 2009-04-01 0

GESSLER MARK D

  • Director
0 2008-05-23 0

DIMMLER CHARLES L III CEO & PRESIDENT

  • Officer
  • Director
0 2008-04-24 0

ROHRER PHILIP L JR CHIEF FINANCIAL OFFICER

  • Officer
0 2008-04-24 0

STAPLES F DUDLEY JR SENIOR VP, SECRETARY

  • Officer
0 2008-04-24 0

TIFFANY LARRY M SVP & INTERIM GM GEMONICS

  • Officer
0 2008-04-24 0

MILLER LLOYD I III

  • NO LONGER DIRECTOR
No longer subject to file 2008-03-14 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments